SYNH - Syneos Health Inc - Class A
Close
42.98
0.010 0.023%
Share volume: 0
Last Updated: Wed 27 Sep 2023 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.97
0.01
0.02%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-04-29 | 2022-08-02 | 2022-11-04 | 2023-02-16 | 2023-05-10 | 2023-08-09 | |
| Total revenue | 1.336 B | 1.361 B | 1.336 B | 1.360 B | 1.357 B | 1.366 B | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.336 B | 1.361 B | 1.336 B | 1.360 B | 1.357 B | 1.366 B | |
| 1.83% | -1.80% | 1.77% | -0.23% | 0.68% | |||
| Operating expenses | 140.166 M | 139.040 M | 130.355 M | 137.693 M | 161.517 M | 182.523 M | |
| Selling general and admin | 140.166 M | 139.040 M | 130.355 M | 137.693 M | 161.517 M | 182.523 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 1.247 B | 1.235 B | 1.210 B | 1.242 B | 1.312 B | 1.313 B | |
| -0.93% | -2.06% | 2.64% | 5.64% | 0.12% | |||
| Operating income | 89.453 M | 125.581 M | 126.570 M | 118.229 M | 45.147 M | 52.862 M | |
| Ebit | 89.453 M | 125.581 M | 126.570 M | 118.229 M | 45.147 M | 52.862 M | |
| Pretax income | 53.492 M | 103.684 M | 116.685 M | 40.704 M | -75.162 M | 661.000 K | |
| 93.83% | 12.54% | -65.12% | -284.66% | -100.88% | |||
| Income tax | 7.316 M | 25.940 M | 29.636 M | -14.824 M | -3.013 M | -132.000 K | |
| Net income basic | 46.176 M | 77.744 M | 87.049 M | 55.528 M | -72.149 M | 793.000 K | |
| 68.36% | 11.97% | -36.21% | -229.93% | 101.10% | |||
| Net income | 46.176 M | 77.744 M | 87.049 M | 55.528 M | -72.149 M | 793.000 K | |
| 68.36% | 11.97% | -36.21% | -229.93% | 101.10% |